Albano Domenico, Rodella Carlo, Tucci Alessandra, Treglia Giorgio, Bertagna Francesco, Chiti Arturo, Fallanca Federico
Nuclear Medicine, ASST Spedali Civili Brescia, 25123 Brescia, Italy.
Nuclear Medicine, Università degli Studi di Brescia, 25125 Brescia, Italy.
J Clin Med. 2025 Jun 27;14(13):4582. doi: 10.3390/jcm14134582.
Extranodal NK-/T-cell lymphoma (ENKTCL) is a rare and highly aggressive lymphoma with a bad prognosis. The aim of our analysis is to evaluate existing research on the potential usefulness of fluorine-18-fluorodeoxyglucose positron emission tomography or positron/computed tomography (2-[18F]FDG PET or PET/CT) in the management of patients with ENKTCL. A complete search of the literature was conducted across Scopus, PubMed/MEDLINE, and Embase databases, focusing on articles published up to March 2025. A total of 21 studies that investigated the role of 2-[18F]FDG PET or PET/CT in ENKTCL were included in our analysis. The main findings from the literature analysis were (1) 2-[18F]FDG PET/CT seems to be helpful in staging settings, showing a better diagnostic performance than conventional imaging and a positive impact on clinical stage; (2) 2-[18F]FDG PET/CT had excellent negative predictive value for detecting bone marrow involvement, especially in early-stage disease; and (3) qualitative and semiquantitative PET parameters might predict prognosis. Despite several limitations affecting this analysis, especially related to the heterogeneity of the studies included, 2-[18F]FDG PET/CT seems to be a useful tool for the evaluation of ENKTCL.
结外NK/T细胞淋巴瘤(ENKTCL)是一种罕见且侵袭性很强的淋巴瘤,预后较差。我们分析的目的是评估关于氟-18-氟脱氧葡萄糖正电子发射断层扫描或正电子/计算机断层扫描(2-[18F]FDG PET或PET/CT)在ENKTCL患者管理中潜在效用的现有研究。我们在Scopus、PubMed/MEDLINE和Embase数据库中对文献进行了全面检索,重点关注截至2025年3月发表的文章。共有21项研究调查了2-[18F]FDG PET或PET/CT在ENKTCL中的作用,纳入了我们的分析。文献分析的主要结果是:(1)2-[18F]FDG PET/CT在分期方面似乎有帮助,显示出比传统成像更好的诊断性能,并且对临床分期有积极影响;(2)2-[18F]FDG PET/CT在检测骨髓受累方面具有出色的阴性预测价值,尤其是在疾病早期;(3)PET的定性和半定量参数可能预测预后。尽管该分析存在一些局限性,特别是与纳入研究的异质性有关,但2-[18F]FDG PET/CT似乎是评估ENKTCL的有用工具。